Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbonic Anhydrase Inhibitors | 4 | 2021 | 22 | 2.470 |
Why?
|
| Anticonvulsants | 3 | 2021 | 376 | 1.450 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 1759 | 0.940 |
Why?
|
| Sulfonamides | 2 | 2018 | 280 | 0.930 |
Why?
|
| Methyltransferases | 1 | 2025 | 78 | 0.890 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2021 | 4 | 0.730 |
Why?
|
| Structure-Activity Relationship | 6 | 2025 | 566 | 0.720 |
Why?
|
| Nuclear Proteins | 1 | 2025 | 1206 | 0.610 |
Why?
|
| Benzene Derivatives | 1 | 2018 | 20 | 0.560 |
Why?
|
| Seizures | 2 | 2018 | 847 | 0.460 |
Why?
|
| Rats, Wistar | 3 | 2021 | 307 | 0.420 |
Why?
|
| Drug Design | 3 | 2021 | 153 | 0.410 |
Why?
|
| Carbonic Anhydrases | 2 | 2021 | 19 | 0.310 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2587 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2025 | 1602 | 0.290 |
Why?
|
| Drug Discovery | 2 | 2021 | 173 | 0.280 |
Why?
|
| Cell Proliferation | 2 | 2025 | 2400 | 0.250 |
Why?
|
| RNA Recognition Motif | 1 | 2025 | 1 | 0.240 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2025 | 37 | 0.240 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2025 | 24 | 0.230 |
Why?
|
| Animals | 8 | 2025 | 33234 | 0.230 |
Why?
|
| Mice | 5 | 2025 | 17699 | 0.230 |
Why?
|
| Carbazoles | 1 | 2025 | 28 | 0.230 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2025 | 74 | 0.220 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2025 | 25 | 0.220 |
Why?
|
| Molecular Structure | 2 | 2025 | 307 | 0.220 |
Why?
|
| Protein Aggregates | 1 | 2025 | 31 | 0.220 |
Why?
|
| Sarcoma, Ewing | 1 | 2025 | 111 | 0.220 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2025 | 156 | 0.220 |
Why?
|
| Acetamides | 1 | 2024 | 44 | 0.200 |
Why?
|
| Rats | 2 | 2021 | 3399 | 0.200 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2025 | 173 | 0.190 |
Why?
|
| RNA | 1 | 2025 | 518 | 0.190 |
Why?
|
| Dengue Virus | 1 | 2023 | 131 | 0.190 |
Why?
|
| Dengue | 1 | 2023 | 121 | 0.180 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2021 | 58 | 0.180 |
Why?
|
| Zika Virus | 1 | 2023 | 152 | 0.180 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 106 | 0.180 |
Why?
|
| Carbonic Anhydrase I | 1 | 2021 | 1 | 0.180 |
Why?
|
| Carbonic Anhydrase II | 1 | 2021 | 1 | 0.180 |
Why?
|
| Zika Virus Infection | 1 | 2023 | 176 | 0.170 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 220 | 0.170 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2021 | 237 | 0.160 |
Why?
|
| Mice, Nude | 1 | 2021 | 708 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 984 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 380 | 0.150 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 399 | 0.150 |
Why?
|
| Apoptosis | 2 | 2025 | 1825 | 0.150 |
Why?
|
| Pentylenetetrazole | 1 | 2018 | 21 | 0.140 |
Why?
|
| Convulsants | 1 | 2018 | 19 | 0.140 |
Why?
|
| Electroshock | 1 | 2018 | 27 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3505 | 0.140 |
Why?
|
| Postural Balance | 1 | 2018 | 130 | 0.130 |
Why?
|
| Humans | 10 | 2025 | 127627 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2017 | 405 | 0.120 |
Why?
|
| Epilepsy | 1 | 2021 | 844 | 0.100 |
Why?
|
| Male | 3 | 2021 | 62967 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2852 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2025 | 140 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 114 | 0.060 |
Why?
|
| Protein Folding | 1 | 2025 | 215 | 0.060 |
Why?
|
| Urea | 1 | 2025 | 224 | 0.060 |
Why?
|
| Protein Domains | 1 | 2025 | 239 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 19 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2025 | 803 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 357 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 247 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 149 | 0.040 |
Why?
|
| Binding Sites | 1 | 2021 | 1187 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 778 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1110 | 0.030 |
Why?
|
| Female | 1 | 2021 | 68835 | 0.030 |
Why?
|
| Mutation | 1 | 2025 | 5953 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8391 | 0.020 |
Why?
|